Pareto, Deborah http://orcid.org/0000-0001-7356-3769
Garcia-Vidal, Aran
Groppa, Sergiu
Gonzalez-Escamilla, Gabriel
Rocca, Mara
Filippi, Massimo
Enzinger, Christian
Khalil, Michael
Llufriu, Sara
Tintoré, Mar
Sastre-Garriga, Jaume
Rovira, Àlex
Funding for this research was provided by:
Instituto de Salud Carlos III (PI18/00823)
Article History
Received: 27 August 2021
Accepted: 15 December 2021
First Online: 20 January 2022
Declarations
:
: The study was approved by the local ethics committee, under the standards of the 1964 Declaration of Helsinki.
: All patients signed an informed consent for participation.
: DP has received speaking honoraria from Novartis and Sanofi-Genzyme and a research contract from Biogen.AG-V has nothing to disclose.SG has nothing to disclose.GG-E has nothing to disclose.MR received speaker honoraria from Biogen Idec, Novartis, Genzyme, Teva, Merck Serono, Roche, Celgene and Bayer and receives research support from the Italian Ministry of Health, MS Society of Canada and Fondazione Italiana Sclerosi Multipla.MF: Editor-in-Chief of the Journal of Neurology received compensation for consulting services and/or speaking activities from Bayer, Biogen Idec, Merck-Serono, Novartis, Roche, Sanofi Genzyme, Takeda, and Teva Pharmaceutical Industries; and receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, Teva Pharmaceutical Industries, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, and ARiSLA (Fondazione Italiana di Ricerca per la SLA).MK has received funding for travel and speaker honoraria from Bayer Schering Pharma, Novartis Genzyme, Merck Serono, Biogen Idec and Teva Pharmaceutical Industries Ltd. and serves on scientific advisory boards for Biogen Idec, Merck Serono and Roche.CH received funding for travel and speaker honoraria from Bayer, Biogen, Genzyme, Merck, Novartis, Roche, Shire, and Teva Pharmaceutical Industries Ltd./sanofi-aventis, research support from Biogen, Merck, and Teva Pharmaceutical Industries Ltd./sanofi-aventis and serving on scientific advisory boards for Bayer, Biogen, Merck, Novartis, Roche and Teva Pharmaceutical Industries Ltd./sanofi- Aventis.SL received compensation for consulting services and speaker honoraria from Biogen Idec, Novartis, TEVA, Genzyme, Sanofi, Roche, and Merck.MT has received speaking honoraria and travel expenses for scientific meetings with Amirall, Bayer, Biogen Idec, Genzyme, Merck Serono, Novartis, Sanofi-Aventis, Roche, and Teva.JSG is Director of <i>Revista de Neurología</i> and serves on the Editorial Board of MSJ. In the last 36 months he has received compensation for serving on scientific advisory boards or on speaker’s bureaus from Biogen, Merck, Almirall, Novartis, Teva, Roche, Celgene, and Genzyme.ÀR has served on scientific advisory boards for Novartis, Sanofi-Genzyme, Icometrix, Bayer SyntheticMR, and OLEA Medical and has received speaking honoraria from Bayer, Sanofi-Genzyme, Bracco, Merck-Serono, Teva Pharmaceutical Industries Ltd, Novartis, Roche, and Biogen Idec.